Clinical Trial Update: BOTOX® vs. XEOMIN® for Chronic Migraine [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating head-to-head efficacy of Botox (onabotulinumtoxinA) versus XEOMIN (incobotulinumtoxinA) for chronic migraine; recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Naval Medical Center Camp Lejeune | Conditions: Chronic Migraine | Phase 3 | Status: RECRUITING